BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240723T130000
DTEND;TZID=America/Halifax:20240723T140000
DTSTAMP:20260610T222616
CREATED:20240718T161933Z
LAST-MODIFIED:20241024T183050Z
UID:10000777-1721739600-1721743200@staging.digitalinsights.supremeclients.com
SUMMARY:Assessing drug safety with QIAGEN Biomedical KB-AI
DESCRIPTION:Are you a healthcare professional\, clinical researcher or data scientist interested in drug safety research? If so\, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. Focusing on immune checkpoint inhibitors (ICIs)\, we will also demonstrate how Neo4j and Python can be combined to query\, visualize and analyze this data effectively. \nWe’ll cover the following: \n\nDrug safety profiling in Biomedical KB-AI\nPharmacovigilance case study of ICIs: Pembrolizumab\nComparative analysis of ICIs for comprehensive safety monitoring
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/assessing-drug-safety-with-qiagen-biomedical-kb-ai/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240723T130000
DTEND;TZID=America/Halifax:20240723T140000
DTSTAMP:20260610T222616
CREATED:20240808T095714Z
LAST-MODIFIED:20241024T182418Z
UID:10000555-1721739600-1721743200@staging.digitalinsights.supremeclients.com
SUMMARY:Assessing drug safety with QIAGEN Biomedical KB-AI
DESCRIPTION:Are you a healthcare professional\, clinical researcher or data scientist interested in drug safety research? If so\, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. Focusing on immune checkpoint inhibitors (ICIs)\, we will also demonstrate how Neo4j and Python can be combined to query\, visualize and analyze this data effectively. \nWe’ll cover the following: \n\nDrug safety profiling in Biomedical KB-AI\nPharmacovigilance case study of ICIs: Pembrolizumab\nComparative analysis of ICIs for comprehensive safety monitoring
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/assessing-drug-safety-with-qiagen-biomedical-kb-ai-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
END:VCALENDAR